The use of intranasal NEO100 as an agent to treat a neurological disease such as GBM is unique in that it suggests the feasibility of nasal brain delivery via the cranial nerves, thereby avoiding the obstacle presented by the BBB. This delivery method also reduces exposure through the systemic circulation, by that minimizing the systemic […]